192 related articles for article (PubMed ID: 26904942)
1. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
3. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
4.
León TE; Rapoz-D'Silva T; Bertoli C; Rahman S; Magnussen M; Philip B; Farah N; Richardson SE; Ahrabi S; Guerra-Assunção JA; Gupta R; Nacheva EP; Henderson S; Herrero J; Linch DC; de Bruin RAM; Mansour MR
Cancer Discov; 2020 Jul; 10(7):998-1017. PubMed ID: 32349972
[TBL] [Abstract][Full Text] [Related]
5. A new hope for early T cell precursor acute lymphoblastic leukemia therapy based on STAT5+ leukemic stem cell targeting.
Pelayo R
J Leukoc Biol; 2023 Oct; 114(5):381-383. PubMed ID: 37607260
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the histone methyltransferase Ezh2 drive context-dependent leukemia in Xenopus tropicalis.
Tulkens D; Boelens M; Naert T; Carron M; Demuynck S; Dewaele S; Van Isterdael G; Creytens D; Pieters T; Goossens S; Van Vlierberghe P; Vleminckx K
Leukemia; 2023 Dec; 37(12):2404-2413. PubMed ID: 37794102
[TBL] [Abstract][Full Text] [Related]
7. Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline
Tibout P; Livingston J; Kanwar N; Yuki KE; Shlien A; Ngan B; Irwin MS; Morgenstern DA; Hitzler J; Villani A; Cohen-Gogo S
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37932047
[TBL] [Abstract][Full Text] [Related]
8. Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.
Vanden Bempt M; Debackere K; Demeyer S; Van Thillo Q; Meeuws N; Prieto C; Provost S; Mentens N; Jacobs K; Gielen O; Nittner D; Ogawa S; Kataoka K; Graux C; Tousseyn T; Cools J; Dierickx D
Blood; 2022 Dec; 140(23):2463-2476. PubMed ID: 35960849
[TBL] [Abstract][Full Text] [Related]
9. The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
Murgo E; De Santis E; Sansico F; Melocchi V; Colangelo T; Padovano C; Colucci M; Carbone A; Totti B; Basti A; Gottschlich L; Relogio A; Capitanio N; Bianchi F; Mazzoccoli G; Giambra V
J Exp Clin Cancer Res; 2023 Aug; 42(1):218. PubMed ID: 37620852
[TBL] [Abstract][Full Text] [Related]
10. Targeting STAT5B in T-cell acute lymphoblastic leukemia.
Veloso A; Cools J
Blood; 2023 Jul; 142(3):215-217. PubMed ID: 37471110
[No Abstract] [Full Text] [Related]
11. Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.
Castaneda Puglianini O; Papadantonakis N
Ther Adv Hematol; 2020; 11():2040620720929475. PubMed ID: 32733662
[TBL] [Abstract][Full Text] [Related]
12. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
[TBL] [Abstract][Full Text] [Related]
13. The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities.
Bernt KM; Hunger SP; Neff T
Front Pediatr; 2016; 4():49. PubMed ID: 27242978
[TBL] [Abstract][Full Text] [Related]
14. Beating the Clock in T-cell Acute Lymphoblastic Leukemia.
Carroll WL; Aifantis I; Raetz E
Clin Cancer Res; 2017 Feb; 23(4):873-875. PubMed ID: 28007775
[TBL] [Abstract][Full Text] [Related]
15. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
16. Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.
Lu Z; Xie J; Wu G; Shen J; Collins R; Chen W; Kang X; Luo M; Zou Y; Huang LJ; Amatruda JF; Slone T; Winick N; Scherer PE; Zhang CC
Nat Med; 2017 Jan; 23(1):79-90. PubMed ID: 27941793
[TBL] [Abstract][Full Text] [Related]
17. Regulation of T Cell Differentiation and Function by EZH2.
Karantanos T; Chistofides A; Barhdan K; Li L; Boussiotis VA
Front Immunol; 2016; 7():172. PubMed ID: 27199994
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of EZH2 expression in myelodysplastic syndromes.
Cabrero M; Wei Y; Yang H; Ganan-Gomez I; Bohannan Z; Colla S; Marchesini M; Bravo GM; Takahashi K; Bueso-Ramos C; Garcia-Manero G
Leuk Res; 2016 May; 44():1-7. PubMed ID: 26970171
[TBL] [Abstract][Full Text] [Related]
19. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.
Göllner S; Oellerich T; Agrawal-Singh S; Schenk T; Klein HU; Rohde C; Pabst C; Sauer T; Lerdrup M; Tavor S; Stölzel F; Herold S; Ehninger G; Köhler G; Pan KT; Urlaub H; Serve H; Dugas M; Spiekermann K; Vick B; Jeremias I; Berdel WE; Hansen K; Zelent A; Wickenhauser C; Müller LP; Thiede C; Müller-Tidow C
Nat Med; 2017 Jan; 23(1):69-78. PubMed ID: 27941792
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors.
Beyaz S; Mana MD; Roper J; Kedrin D; Saadatpour A; Hong SJ; Bauer-Rowe KE; Xifaras ME; Akkad A; Arias E; Pinello L; Katz Y; Shinagare S; Abu-Remaileh M; Mihaylova MM; Lamming DW; Dogum R; Guo G; Bell GW; Selig M; Nielsen GP; Gupta N; Ferrone CR; Deshpande V; Yuan GC; Orkin SH; Sabatini DM; Yilmaz ÖH
Nature; 2016 Mar; 531(7592):53-8. PubMed ID: 26935695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
